by editor | Jun 21, 2023 | Clinicians, Participants, Researchers
Low-dose aspirin may increase anemia risk in healthy older adults: study A new study analysing data from the landmark ASPREE trial has found that prolonged daily aspirin use increases the risk of anemia by 20% in some older adults, mostly aged over 70 years (65...
by editor | Aug 30, 2021 | Clinicians, Media, Participants
High long term blood pressure variability (BPV) in older adults, particularly men, is associated with an increased risk of dementia and cognitive decline. A new analysis of ASPREE data found a link between variability of blood pressure in older adults,...
by editor | Jul 6, 2021 | Participants
Important information about ASPREE-XT study visits and COVID-19 ANNOUNCEMENT In light of public health recommendations to help slow the spread of Coronavirus (COVID-19) in the community, ASPREE-XT is conducting both face-to-face visits and phone calls, so...
by editor | Aug 1, 2019 | Clinicians, Participants, Researchers
Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly ANNOUNCEMENT: Landmark ASPREE study extended for five years to track study participants for long-term health outcomes after discontinuing aspirin. ASPREE-XT will investigate...
by editor | Sep 17, 2018 | Clinicians, Participants, Researchers
Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people For decades, doctors have been prescribing low-dose aspirin for healthy people over the age of 70. from shutterstock.com John McNeil, Monash University Taking low-dose aspirin daily...
Recent Comments